Exascale Labs Holdings (XLAB) Insider & Congress Trades

Smart money at a glance

Filings to Oct 31, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes

Analysts

What do analysts expect?

No analyst estimates.

Questions about XLAB filings

Are insiders buying or selling Exascale Labs Holdings Inc. Class A Common Stock (XLAB) stock?

Neither. Exascale Labs Holdings Inc. Class A Common Stock (XLAB) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded XLAB recently?

None. No member of Congress disclosed a XLAB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this XLAB smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

Questions about XLAB filings

Are insiders buying or selling Exascale Labs Holdings Inc. Class A Common Stock (XLAB) stock?

Neither. Exascale Labs Holdings Inc. Class A Common Stock (XLAB) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded XLAB recently?

None. No member of Congress disclosed a XLAB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this XLAB smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Sep 28, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Sep 28, 2026

Period ending

Jun 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue (FY)

$14.8M

Year ended Jun 30, 2026 · SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Sep 28, 2026	Not on file	No estimate	$14.8M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $4.37
52-wk high: $7.39
High: $4.48
52-wk low: $0.78
Low: $3.22
Prev close: $4.71
Mkt cap: $202.7M
ROE: +0.0%
P/S: 13.7x
Profit margin: -82.1%
Op margin: -46.5%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -82.1%
Market cap: $203M

Valuation

P/S13.67

Quality

Operating margin-46.5%
ROE0.0%
ROA-42.7%

Growth

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

65balanced

20D volatility

385%annualized

52-week range

$3.35

$0.78$7.39

20D support

$0.78recent floor

20D resistance

$4.85recent ceiling

Returns

5D +42.6%20D +37.9%

Price vs moving averages

SMA20 +76.1%

Volume pace

45.62xvs prior 20D

Smart money at a glance

Filings to Oct 31, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes

Analysts

What do analysts expect?

No analyst estimates.

Questions about XLAB filings

Are insiders buying or selling Exascale Labs Holdings Inc. Class A Common Stock (XLAB) stock?

Neither. Exascale Labs Holdings Inc. Class A Common Stock (XLAB) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded XLAB recently?

None. No member of Congress disclosed a XLAB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this XLAB smart-money data?

No recent filings found.

Questions about XLAB filings

Are insiders buying or selling Exascale Labs Holdings Inc. Class A Common Stock (XLAB) stock?

Neither. Exascale Labs Holdings Inc. Class A Common Stock (XLAB) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded XLAB recently?

None. No member of Congress disclosed a XLAB trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this XLAB smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Sep 28, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Sep 28, 2026

Period ending

Jun 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue (FY)

$14.8M

Year ended Jun 30, 2026 · SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Sep 28, 2026	Not on file	No estimate	$14.8M · FYSEC filing	No year-ago quarter

Open: $4.37
52-wk high: $7.39
High: $4.48
52-wk low: $0.78
Low: $3.22
Prev close: $4.71
Mkt cap: $202.7M
ROE: +0.0%
P/S: 13.7x
Profit margin: -82.1%
Op margin: -46.5%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -82.1%
Market cap: $203M

Valuation

P/S13.67

Quality

Operating margin-46.5%
ROE0.0%
ROA-42.7%

Growth

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

65balanced

20D volatility

385%annualized

52-week range

$3.35

$0.78$7.39

20D support

$0.78recent floor

20D resistance

$4.85recent ceiling

Returns

5D +42.6%20D +37.9%

Price vs moving averages

SMA20 +76.1%

Volume pace

45.62xvs prior 20D

Exascale Labs Holdings Inc. Class A Common Stock

Smart money at a glance

What do analysts expect?

Questions about XLAB filings

Questions about XLAB filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Exascale Labs Holdings Inc. Class A Common Stock

Smart money at a glance

What do analysts expect?

Questions about XLAB filings

Questions about XLAB filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Exascale Labs Holdings Inc. Class A Common Stock

Overview

Questions about XLAB filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Exascale Labs Holdings Inc. Class A Common Stock

Overview

Questions about XLAB filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.